Brian J. Blaser - 01 Dec 2021 Form 4 Insider Report for Talis Biomedical Corp (TLIS)

Role
President and CEO, Director
Signature
/s/ J. Roger Moody, Jr., Attorney-in-Fact for Brian Blaser
Issuer symbol
TLIS
Transactions as of
01 Dec 2021
Transactions value $
$0
Form type
4
Filing time
02 Dec 2021, 16:04:39 UTC
Previous filing
20 Oct 2021
Next filing
25 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLIS Stock Option (right to buy) Award $0 +750K $0.00 750K 01 Dec 2021 Common Stock 750K $4.47 Direct F1
transaction TLIS Restricted Stock Units Award $0 +625K $0.00 625K 01 Dec 2021 Common Stock 625K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 20% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/60th of the shares underlying this option shall vest monthly thereafter over 48 months.
F2 Each restricted stock unit represents a contingent right to receive one share of the Company's common stock upon vesting.
F3 20% of the shares shall vest on the first annual anniversary of the vesting commencement date and the balance of the shares will vest in a series of four equal successive annual installments.